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Abstract: The location of the loss of the inner segment (IS)/outer segment 
(OS) border, as seen with frequency domain optical coherence tomography 
(fdOCT), was determined on fdOCT scans from patients with retinitis 
pigmentosa. A comparison to visual field loss supported the hypothesis, 
based upon previous work, that the point at which the IS/OS border 
disappears provides a structural marker for the edge of the visual field. 
Repeat fdOCT measures showed good within day reproducibility, while 
data obtained on average 22.5 months later showed signs of progression. 
The IS/OS contour shows promise as a measure for following changes in 
patients undergoing treatment. 
©2011 Optical Society of America 
OCIS codes: (170.4500) Optical coherence tomography; (330.4300) Vision system - 
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1. Introduction 
The loss of vision due to heredodegenerative diseases of the receptors traditionally has been 
followed in the clinic with behaviorally measured visual fields and/or electrophysiologically 
measured electroretinograms. The behavioral techniques, such as standard automated 
perimetry (SAP), have the advantage of providing topographical information about the 
disease process. With the introduction of optical coherence tomography (OCT), it became 
possible to obtain topographical information about the anatomical/structural damage to the 
receptors as well. 
A number of studies have shown a correspondence between a loss of light sensitivity with 
SAP and a decrease in receptor layer thickness on OCT scans. Earlier studies with time 
domain OCT showed good quantitative agreement between the extent of local field loss and 
the thickness of the outer nuclear layer (ONL) [1–4]. With the improved resolution of 
frequency domain (fd) OCT, it became possible to measure the thickness of the outer segment 
(OS) layer. Rangaswamy et al. [5], for example, found that the OS thickness decreased 
approximately linearly with local field loss, becoming non-detectable in regions where visual 
field sensitivity loss was worse than 10 dB. A study of the transition zone from regions of 
normal to abnormal vision reported that the earliest sign of damage in RP was a thinning of 
the OS layer, followed by a decrease in ONL thickness, and then a disappearance of the OS 
layer [6]. The disappearance of the OS layer occurs, by definition, at the point where the so-
called inner segment (IS)/OS border is no longer visible. 
What is called the IS/OS border is a prominent and clearly visible landmark on OCT 
scans. Whether this is in fact the IS/OS border or the ellipsoids at the distal ends of the IS is 
open to debate [7]. In any case, there are many reports of this IS/OS border being disrupted in 
patients with diseases of the outer retina. (See for example [8–10].) Of particular relevance 
here is the finding of Fischer et al. [11] that the distance from the center of the fovea to the 
loss of the IS/OS signal correlated with distance to the edge of the visual field as measured 
with Goldmann perimetry. 
Taken together, these studies suggest that the point at which the IS/OS border disappears 
should correspond to a visual field sensitivity loss of 10 dB and may provide a structural 
marker for the edge of the visual field. Here we test this hypothesis. In addition, we explore 
the use of this OCT marker as a possible measure of disease progression. 
2. Methods 
2.1. Subjects 
Six patients with RP (age 47.8 ± 11.1 yr) were enrolled in this study. Patients were diagnosed 
with RP based on the appearance of the fundus, clinical history, visual fields, and full‐field 
electroretinogram results. All patients had best corrected visual acuity (BCVA) of 20/25 or 
better. Table 1 summarizes some of the clinical characteristics. Twenty healthy controls (age 
51.4 ± 9.4 yr) without visual abnormalities served as controls for the OCT measures. 
A single eye of each patient was tested with SAP (10-2 SITA standard program, Carl 
Zeiss Meditec, Inc. Dublin, CA) and OCT 3D macular cube scans (Topcon, Inc., Paramus, 
NJ, USA). The 10-2 visual field protocol uses a test spot 0.43° in diameter presented on a grid 
of 68 points and against a background is 31.5 cd.m
2. The grid starts ± 1° from the point of 
fixation with the points spaced every 2°. All patients had reliable 10-2 visual fields with 
foveal sensitivities between 32 to 36 dB. With the exception of P3 and P5, the foveal 
sensitivity on the 10-2 was within normal limits. The macular cube scan consisted of 128 line 
scans [B-scans] and covered a 6 mm by 6 mm region, approximately 21° by 21°. Repeat scans 
were obtained at each visit. In addition, the patients were tested again, on average 22.5 mos. 
after the first session. All 6 patients had fdOCT scans on the second visit and 5 of 6 had 10-2 
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movement artifacts. 
Written informed consent was obtained from all subjects. Procedures followed the tenets 
of the Declaration of Helsinki, and the protocol was approved by the Committee of the 
Institutional Board of Research of Columbia University. 
Table 1. Patient characteristics
a 
Patient  Eye  Age  Gender  BCVA Type (genetics) 
10-2 
fovea 
(dB) 
10-
2 MD 
(dB) 
Time to 
visit 
2 (mos) 
P1  OD  48  F  20/20-2 AR (unknown) 33 7.09  31 
P2  OD  37  M  20/20-1 AD (unknown) 35 27.42  25 
P3  OD  50  F  20/25 Simplex 32 28.37  24 
P4  OD  57  F  20/16 AR (USH2A-E3088K) 35 5.36  24 
P5  OS  35  F  20/25 Usher II (unknown) 32 15.43  21 
P6  OD  62  F  20/16-1 AD (unknown) 36 17.25  10 
aBCVA: best corrected visual acuity; AR: autosomal recessive; AD: autosomal dominant. 
2.2. fdOCT measurements 
For every cube scan, 11 individual B-scans were manually segmented. The B-scans chosen 
included the one centered on the fovea (0°) and 10 others located at: ± 1°, ± 3°, ± 5°, ± 7°, and 
± 9° from the center. The B-scan centered on the fovea was selected based upon the following 
criteria: the presence of a bright light reflex/artifact; the depth of the foveal depression; and 
the prominence of the peak in the IS/OS line. The manual segmentation procedure has been 
previously described [12,13]. For our purpose here, the IS/OS (red) line and the proximal 
(vitreal) edge of what is typically taken to be the retinal pigment epithelium (RPE) (green) 
were marked as shown in Fig. 1(b) and Fig. 1(c). The difference between these borders was 
taken as the OS thickness. The OS thickness was measured to provide an objective method for 
locating the loss of the IS/OS border. Figure 2 illustrates this procedure with the line scan 
shown in Fig. 1. The location of this line scan corresponds to the horizontal dashed red line in 
Fig. 2(a),(b) superimposed on P1’s 10-2 visual field. In Fig. 2(c), the OS thickness (red curve) 
is plotted versus retinal location for this scan; the black curves are the mean and 95% 
confidence intervals for the control group. The location at which the OS/IS border is lost is 
estimated as the point at which the OS thickness reaches the zero thickness line (dashed 
horizontal line), as indicated by the red circle. This location is also indicated with the red 
circle on the visual field in panel A. A similar procedure was followed for the 10 other scans 
positioned as shown in Fig. 2(b) to correspond to the locations of the 10-2 visual field points. 
This method of locating the edge of the IS/OS border agreed with the visual identification of 
its complete disappearance. That is, in a few cases the border appeared to be interrupted 
before it disappeared. While this region may be of interest to study in the future, here we 
ignored this section and marked only the point at which the IS/OS line disappeared as this 
point could be unambiguously determined. 
3. Results 
3.1. IS/OS contours 
Figure 3 summarizes the results for all 6 patients, ordered based upon the extent of the intact 
visual field. The black circles indicate the locations of the 10-2 test points and the red dots the 
locations of the end (disappearance) of the IS/OS border. We will refer to the red curve 
connecting these points as the ‘IS/OS contour’. (The dashed lines in Fig. 3 are estimated 
regions of the IS/OS contour and indicate a place where the exact location of the IS/OS  
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Fig. 1. fdOCT scan through the horizontal meridian of P1. (a) Scan before segmentation. (b) 
Scan after segmentation of IS/OS (red) and OS/RPE (green) boundaries. (c) Expanded view of 
portion within white rectangle in panel (b). 
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Fig. 2. An illustration of the procedure for estimating the end of the IS/OS border using the 
horizontal scan for P1 shown in Fig. 1. (a) The 10-2 total deviation plot. (b) Same as panel A 
with the location of the scans segmented. (c) The thickness of the OS layer as a function of 
distance across the scan shown in Fig. 1. The dashed lines indicate zero OS thickness 
(horizontal) and the center of the fovea (vertical). 
disappearance was uncertain due to the sparse vertical spacing of the segmented scans.) The 
numbers inside the black circles are the loss in sensitivity (total deviation in dB) relative to a 
control group for each patient’s 10-2 visual field. 
We hypothesized that the termination of the IS/OS border should correspond 
approximately to a visual field loss of 10 dB [5]. The visual field points of 10 dB or worse 
are shown in red. Of the 408 points in Fig. 3, 3 (<1%) of the points coded red (10 dB or 
worse) fell inside the red IS/OS contour, while 36 (<9%) of the points outside the red 
contours were not red (i.e. 9 dB or better). The agreement with the 10 dB hypothesis 
appears to be good, but it would be slightly better if a cutoff of 8 dB were used for this data 
set (see below). Of the 36 ‘discrepant’ points outside the IS/OS contour, 24 (67%) were 8 or 
9 dB. Only 12 points better than 8 dB fell outside the IS/OS contour and only 4 of these 
points had visual field sensitivities better than 5 dB (red circles), well within the 95% 
confidence intervals for visual field measurements. That is, the agreement is even better than 
it appears if the variability of the visual field measures is taken into consideration. In any 
case, the issue here is not the particular value of the field loss that best agrees with the IS/OS 
contour. Rather, it appears from Fig. 3 that this contour falls, in general, in the region of a 
marked loss in field sensitivity. To obtain a quantitative measure of this qualitative 
observation, we compared the sensitivity of the visual field points adjacent to the inside of the 
IS/OS contour to those adjacent to the outside. The median of all points adjacent to the inside 
of this contour was 4 dB as compared to 12 dB for those just outside, a difference of 8 dB 
or a change in sensitivity by a factor of more than 6. 
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Fig. 3. IS/OS contours and visual fields. A dashed line was used where the exact location of the 
IS/OS disappearance was uncertain due to the sparse vertical spacing of the segmented scans. 
(a) The 10-2 visual field losses (total deviation in dB) are shown with the boundary (red curve) 
of the IS/OS loss for patient P1. Visual field losses of 10 or worse are shown in red. (b)-(f). 
Same as in (a) for the other 5 patients. 
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All patients had repeat scans taken at each session The red curves in Fig. 4 are the result of 
the segmentation of the two scans for the first visit and the green curves are the results for the 
second visit, 10 to 31 months later. For all 6 patients, the mean difference between IS/OS 
contour on the 2 scans repeated on the same visit was 0.00 ± 0.12mm and 0.11 ± 0.16mm, for 
the first and second visits respectively, or on average < 0.2 degrees in visual angle on the 
field. (The average of the mean of the absolute differences was 0.18 ± 0.06mm and 0.17 ± 
0.13mm or about 0.6 degrees.) 
3.3. A possible method for following progression 
The patients returned for repeat 10-2 fields and fdOCT scans between 10 and 31 months later. 
The number in each black circle in Fig. 4 is the difference in dB between visual field test 
sensitivity on the two occasions (visit 2 minus visit 1). In particular, a negative number means 
that the more recent field at that point showed a more negative (poorer) total deviation score, 
while a positive number indicates the more recent field had a better total deviation score. To 
help visualize changes in the visual field, differences of 5 dB or worse were colored pink, 
while changes of 5 dB or better were coded green. (Note due to an error, P1 did not have a 10-
2 test on visit 2.) 
For the IS/OS contours, in general the earlier measures (red) fell outside the more recent 
measures (green). To obtain a quantitative measure of this, the location of the two IS/OS 
contours were averaged and then the locations of the IS/OS contours for the different sessions 
were compared point by point for each patient. The IS/OS contour moved closer to the center 
of fixation on average by 0.21 ± 0.18 mm. For the individual patients, these values were P1: 
0.51 mm; P2: 0.08 mm; P3: 0.29 mm; P4: 0.24 mm; P5: 0.02 mm; and P6: 0.18 mm. 
To make a quantitative comparison to the change in the visual fields, we compared the 
difference in mean deviation (MD) values between the two visits to the change in the position 
of the IS/OS contour between visits. For the 5 patients on whom we had repeat 10-2 scans, on 
average, the movement of the IS/OS contour of 0.16 mm was associated with an average 
change in MD of 4.02 dB. 
3.4. Local OS thickness vs. local sensitivity change 
In order to quantitatively test the hypothesis that field losses of 10 dB or more correspond to 
regions without a measurable OS layer [5], the normalized OS thickness was plotted against 
visual field loss in Fig. 5. Each small point in Fig. 5 shows the OS thickness and visual field 
loss for an individual field point of an individual patient at the first visit. To normalize the OS 
thickness at each retinal location for each patient, the OS thickness was divided by the OS 
thickness of the controls at that point. This was necessary to adjust for the variation in OS 
thickness with eccentricity seen in controls [5]. 68 data points, corresponding to the 68 test 
points on the 10-2, are shown for each of the 6 patients (different colors). Except for one 
(green) data point, the OS thickness for all visual field points with total deviations worse than 
8 dB (vertical solid black line) cluster around the zero OS line as previously reported [5]. 
The black squares are the mean values for data of equal size bins (x-axis). The mean OS 
thickness is close to zero by the time the mean field loss is 8 dB. Taken together with the 
analysis of Fig. 4, these results suggest that on average, the loss of the IS/OS border 
corresponds better to a loss of 8 dB for this group of patients. As mentioned above, the exact 
value of this cutoff is not important for the method presented here. In fact, from a practical 
point of view, the potential clinical usefulness of the IS/OS contour depends upon the repeat 
reliability of this measure, which is quite good as shown above. 
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Fig. 4. Repeat measures within and across sessions. In each panel, the red and green curves 
show the 2 scans performed on the first (red) and second (green) visits. Black circles indicate 
the location of the 10-2 points and the numbers (in dB) show the change in field sensitivity (in 
dB) between the 2 visits (visit 2-visit 1). 
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Fig. 5. OS thickness versus field loss. The thickness of the OS at each point in the visual field 
is shown for individual patients (small symbols) as a function of the field loss at that point. The 
large symbols are the means of the data grouped into equal sized bins. 
3.5. Limitations and future directions 
All patients in this study had relatively preserved central retinas. Because the IS/OS border 
disappears for field losses greater than about 8 dB, this technique will not be useful for 
patients with severely depressed central fields. For such patients, ONL thickness should be 
explored [6]. Further work is also needed to understand the effects on the IS/OS line of 
different genetic variations of RP, as well as the relative effect of losing local rods as 
compared to a loss of rods and cones. In addition, future work, perhaps with adaptive optics 
[14], should help elucidate the structural basis of the IS/OS line, as well as the changes seen 
with disease. 
4. Conclusion 
The point at which the IS/OS border disappears, the IS/OS contour, shows promise as a 
structural measure of progression. First, the reproducibility of the IS/OS contour showed good 
within day repeatability when the contours from 2 different scans were compared. Second, the 
IS/OS contour exhibited good agreement with a sharp drop in VF sensitivity. Finally, the 
preliminary data presented here suggest this measure of IS/OS contour may be useful in 
following changes in patients undergoing treatment. 
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